Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Arbutus Biopharma (ABUS) Fails to deliver data
Key failure to deliver metrics for Arbutus Biopharma :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $2.08 M
- Last 3 months FTD volume: $4.11 M
- Last year FTD volume: $6.64 M
Failures to deliver for Arbutus Biopharma (ABUS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Arbutus Biopharma (ABUS) - since 2015
Volume in USD (price x number of shares), data since 2015Arbutus Biopharma (ABUS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $4.12 M | -26.01% |
| 2023 | $5.56 M | -48.36% |
| 2022 | $10.78 M | -66.29% |
| 2021 | $31.99 M | 126.41% |
| 2020 | $14.13 M | 677.57% |
| 2019 | $1.81 M | -81.47% |
| 2018 | $9.8 M | 584.44% |
| 2017 | $1.43 M | 75.13% |
| 2016 | $0.81 M | -62.02% |
| 2015 | $2.15 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.03 M | $0.2 M | Bahamas |
 NRC Health
NRC | $0.22 M | $1.46 M | 🇺🇸 USA |